Cargando…
An optimized protocol for patient-derived xenograft in humanized mice to evaluate the role of IL-34 in immunotherapeutic resistance
Previously, we identified a therapy-resistant role of IL-34 in an immune checkpoint blockade in murine models. To investigate whether a similar mechanism is applicable in human tumors as well, we used this protocol for the selection of IL-34-neutralizing antibody and transplanting human tumor tissue...
Autores principales: | Han, Nanumi, Jang, Hye Yoon, Hama, Naoki, Kobayashi, Takuto, Otsuka, Ryo, Wada, Haruka, Seino, Ken-ichiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055705/ https://www.ncbi.nlm.nih.gov/pubmed/33899027 http://dx.doi.org/10.1016/j.xpro.2021.100460 |
Ejemplares similares
-
A mechanism of IL-34-induced resistance against cytotoxic anti-cancer therapies such as radiation by X-ray and chemotherapy by Oxaliplatin
por: Han, Nanumi, et al.
Publicado: (2023) -
Interleukin-34 cancels anti-tumor immunity by PARP inhibitor
por: Nakamura, Takayoshi, et al.
Publicado: (2022) -
Bromodomain-containing protein 4 regulates interleukin-34 expression in mouse ovarian cancer cells
por: Han, Nanumi, et al.
Publicado: (2020) -
Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma
por: Han, Nanumi, et al.
Publicado: (2018) -
Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade
por: Hama, Naoki, et al.
Publicado: (2020)